Regulatory cascades of protein phosphatases: Implications for cancer treatment Journal Article


Authors: Jailkhani, N.; Chaudhri, V. K.; Rao, K. V. S.
Article Title: Regulatory cascades of protein phosphatases: Implications for cancer treatment
Abstract: Coordinated coupling of biochemical reactions involving protein phosphorylation and dephosphorylation represents the hallmark of the intracellular signal transduction machinery. Distinct classes of enzymes known as kinases and phosphatases respectively drive these reactions. Alterations in activity of such signaling intermediates, either due to mutations in the corresponding genes or epigenetic modulation of their expression levels, is often the cause of many cancers. The role of kinases during signal transduction has been extensively investigated over the past several decades and the consensus view is that subsets of kinases form distinct cascades of signaling pathways. Further, the extensive crosstalk that exists between these cascades leads to a complex network configuration for the signaling machinery. Inhibitors of many of these kinases are now being exploited in cancer therapy. In contrast to this, regulation by cellular phosphatases has generally been considered to occur through isolated interactions between a given phosphatase and its target substrate. Emerging evidence, however, is beginning to suggest that phosphatases also inter-regulate each other and that such interactions can lead to the formation of discrete phosphatase-specific cascades. A phosphatase cascade may be defined broadly as a series of successive dephosphorylation reactions that occur within a cell and are catalyzed by phosphatases which are activated sequentially. In general, the term 'phosphatase cascade' refers to cascades that include two or more phosphatase members [1-4]. The crosstalk between such regulatory axes of phosphatase and kinase cascades provides for complex modes of regulation, with non-linear signal input/output relationships. This review discusses the implications of such phosphatase-constituted regulatory elements for both signal processing and transmission. Further, we also explore the potential that insights on the functioning of phosphatase cascades offers, for the development of new and selective strategies for cancer therapy. © 2011 Bentham Science Publishers Ltd.
Keywords: signal transduction; mitogen activated protein kinase; protein kinase b; protein phosphorylation; unclassified drug; gene mutation; review; raf protein; nonhuman; drug targeting; antineoplastic agent; protein bcl 2; unindexed drug; mitogen activated protein kinase p38; stress activated protein kinase; cancer therapy; regulatory mechanism; epigenetics; mitogen activated protein kinase 1; mitogen activated protein kinase 3; protein dephosphorylation; cantharidin; enzyme substrate complex; phosphotransferase; signal processing; enzyme mechanism; rac protein; systems biology; phospholipase c gamma; phosphoprotein phosphatase; protein kinase c gamma; protein kinase lyn; phosphoprotein phosphatase 2a; nsc 95397; combinatorial targeting; kinase cascade; mapk pathway; mkp1; mkp3; phosphatase cascade; pp2a; signaling network; calyculin a; chelerythrine; fostriecin; microcystin; nodularin; nsc 357756; nu 126; okadaic acid; phosphoprotein phosphatase 1; psi 2106; sanguinarine
Journal Title: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11
Issue: 1
ISSN: 1871-5206
Publisher: Bentham Science Publishers  
Date Published: 2011-01-01
Start Page: 64
End Page: 77
Language: English
PROVIDER: scopus
PUBMED: 21214508
DOI/URL:
Notes: --- - "Export Date: 23 June 2011" - "Source: Scopus"
Citation Impact
MSK Authors